Table of Content




1. Executive Summary


2. Global Leber Congenital Amaurosis Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Leber Congenital Amaurosis Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Leber Congenital Amaurosis Market by Type
3.3.1: Therapy
3.3.2: Diagnosis

3.4: Global Leber Congenital Amaurosis Market by Disease Type
3.4.1: Infantile Type
3.4.2: Juvenile Type
3.4.3: Others

3.5: Global Leber Congenital Amaurosis Market by End Use
3.5.1: Hospitals
3.5.2: Specialty Clinics
3.5.3: Ambulatory Surgical Centers
3.5.4: Home Healthcare
3.5.5: Others

3.6: Global Leber Congenital Amaurosis Market by Distribution Channel
3.6.1: Direct Tender
3.6.2: Retail Sales


4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Leber Congenital Amaurosis Market by Region
4.2: North American Leber Congenital Amaurosis Market
4.2.2: North American Leber Congenital Amaurosis Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others


4.3: European Leber Congenital Amaurosis Market
4.3.1: European Leber Congenital Amaurosis Market by Type: Therapy and Diagnosis
4.3.2: European Leber Congenital Amaurosis Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others


4.4: APAC Leber Congenital Amaurosis Market
4.4.1: APAC Leber Congenital Amaurosis Market by Type: Therapy and Diagnosis
4.4.2: APAC Leber Congenital Amaurosis Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others


4.5: ROW Leber Congenital Amaurosis Market
4.5.1: ROW Leber Congenital Amaurosis Market by Type: Therapy and Diagnosis
4.5.2: ROW Leber Congenital Amaurosis Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, and Others



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Leber Congenital Amaurosis Market by Type
6.1.2: Growth Opportunities for the Global Leber Congenital Amaurosis Market by Disease Type
6.1.3: Growth Opportunities for the Global Leber Congenital Amaurosis Market by End Use
6.1.4: Growth Opportunities for the Global Leber Congenital Amaurosis Market by Distribution Channel
6.1.5: Growth Opportunities for the Global Leber Congenital Amaurosis Market by Region

6.2: Emerging Trends in the Global Leber Congenital Amaurosis Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Leber Congenital Amaurosis Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Leber Congenital Amaurosis Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Invitae Corporation
7.2: Spark Therapeutics
7.3: LKC Technologies
7.4: CENTOGENE
7.5: Optos
7.6: Metrovision
7.7: Blue Print Genetics Oy
7.8: CD Genomics
7.9: ProQR Therapeutics
7.10: OCUGEN